ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Alzheimer's drug aims to clear brain plaques
Disease control OngoingThis study tests an experimental drug called RO7126209 in people with early to moderate Alzheimer's disease. The main goal is to see if the drug is safe and how it affects amyloid plaques in the brain. About 241 participants will receive multiple doses of the drug or a placebo th…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 07:55 UTC
-
Could a drug delay Alzheimer's in High-Risk families?
Disease control OngoingThis study tests whether certain drugs can slow memory loss and thinking problems in people who have a genetic mutation that causes Alzheimer's disease. About 490 adults aged 18 to 80 who either know they carry the mutation or are from families with the mutation will receive eith…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
Gum treatment may slow Alzheimer's: new trial launches
Disease control ENROLLING_BY_INVITATIONThis study looks at whether treating severe gum disease can help slow down Alzheimer's disease. The idea is that gum disease causes body-wide inflammation, which may worsen Alzheimer's. Researchers will give 26 people with both conditions either immediate or delayed gum treatment…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Could a new combo drug delay Alzheimer's in High-Risk families?
Disease control OngoingThis study tests whether an experimental drug (E2814) combined with lecanemab can slow Alzheimer's disease in people who carry a genetic mutation that causes it. About 197 adults aged 18-80 with mild or no symptoms will receive either the drug or a placebo for up to 4 years. Rese…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Blood test aims to cut Alzheimer's diagnosis time
Diagnosis TerminatedThis study looked at whether a blood test called PrecivityAD2 could help doctors diagnose Alzheimer's disease faster in people with memory problems. The plan was to compare early versus delayed test results in veterans and other patients. However, the study was withdrawn before a…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: C2N Diagnostics • Aim: Diagnosis
Last updated May 26, 2026 07:54 UTC